ViralLoop

This week on The Drive, I discuss the use of GLP-1 agonists for weight loss. Most notably, semaglutide (e.g., Ozempic, Wegovy) and tirzepatide (Mounjaro). I also discuss metformin as a geroprotective agent, and more, including: Watch/listen: t.co

195 likes27 repliesPosted Mar 13, 2023

Remix this post

Your note

Private to you, and used when you remix this post.

Viral score

Based on absolute engagement — the platform doesn’t expose follower counts here, so large accounts score higher.

From likes, comments.

Why it worked

Opens with a short, self-contained line that is easy to take in at a glance.
Ends on a short line that is easy to quote and repeat.
The opening line stands alone, so it reads completely before the post is expanded.
Written from experience rather than as advice, which is harder to argue with.
Short enough to read in full without expanding, which removes a step before the point lands.
Short sentences keep the pace up, so the reader never has to re-read a line.

The mechanics

Hook: Plain observation
Structure: Hook → Landing
Style: Conversational paragraphs at a steady pace.
Tone: personal
Written for: People building with AI

Analysis by ViralLoop — not written by the original author.

Post by Peter Attia on X